Katie Love, MD, an endocrinologist and principal investigator for the study HSR210198-Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes is currently enrolling participants. The overarching goals of this study is to better understand how and in what ways exercise or a medication called dulaglutide might help people with type 1 diabetes.
Read more about Dr. Love’s study and its real-life applications on the Exercise Physiology Core Laboratory website.
To inquire about referring a patient or enrolling in the study, contact Dr. Love or the study coordinator Lee Hartline.
Filed Under: Research